Genetic approaches in Drosophila for the study neurodevelopmental disorders by Okray, Zeynep
at SciVerse ScienceDirect
Neuropharmacology 68 (2013) 150e156Contents lists availableNeuropharmacology
journal homepage: www.elsevier .com/locate/neuropharmInvited review
Genetic approaches in Drosophila for the study neurodevelopmental disorders
Zeynep Okray a,b,c, Bassem A. Hassan a,b,c,*
a Laboratory of Neurogenetics, VIB Center for the Biology of Disease, VIB, Herestraat 49, Leuven, Belgium
bCenter for Human Genetics, University of Leuven School of Medicine, Leuven, Belgium
c Program in Molecular and Developmental Genetics, Doctoral School of Biomedical Sciences, University of Leuven, Leuven, Belgiuma r t i c l e i n f o
Article history:
Received 13 April 2012
Received in revised form
31 August 2012
Accepted 7 September 2012
Keywords:
Intellectual disability
Neurodevelopmental disorders
Drosophila genetics* Corresponding author. Laboratory of Neurogeneti
of Disease, VIB, Herestraat 49, Leuven, Belgium.
E-mail address: Bassem.Hassan@cme.vib-kuleuven
0028-3908/$ e see front matter  2012 Elsevier Ltd.
http://dx.doi.org/10.1016/j.neuropharm.2012.09.007a b s t r a c t
The fruit fly Drosophila melanogaster is one of the premier genetic model organisms used in biomedical
research today owing to the extraordinary power of its genetic tool-kit. Made famous by numerous
seminal discoveries of basic developmental mechanisms and behavioral genetics, the power of fruit fly
genetics is becoming increasingly applied to questions directly relevant to human health. In this review
we discuss how Drosophila research is applied to address major questions in neurodevelopmental
disorders.
This article is part of the Special Issue entitled ‘Neurodevelopmental Disorders’.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
The nervous system starts out as a flat sheet of cells within the
embryo, which then folds, twists and grows into a mature organ
with hundreds of billions of cells organized into functional units to
receive, process and respond to information. During this process,
complex genetic and molecular interactions ensure that all cells
follow a specified developmental program that leads to their
appropriate role in the system. Defects in the development and
maintenance of a healthy nervous system can compromise cogni-
tive abilities in humans, with most of these defects leading to
diagnoses of neurodevelopmental disorders (NDD) characterized
by intellectual disability (ID). How genetic mutations affect the
development of the brain by disrupting molecular and cellular
networks, ultimately contributing to NDD phenotypes, are large
outstanding questions requiring a fundamental understanding of
how the brainworks. To that end, several animalmodels are used to
study neural development in detail and help provide answers to
these questions.
When using animal models, there is usually a trade-off between
experimental tractability and anatomical and functional relevance
to human disease. The fruit fly, Drosophila melanogaster, offers an
effective solution to this tradeoff. It serves as a powerful tool for
studying brain development and related disorders, as the principles
of nervous system development and function are conserved acrosscs, VIB Center for the Biology
.be (B.A. Hassan).
All rights reserved.lineages. Moreover, its experimental tractability allows rigorous
mechanistic analysis and discovery of brain function. This tracta-
bility extends first from the simplification of the biology of the fly:
with less genetic, cellular and behavioral complexity, it is easier to
establish causeeeffect relationships in the fly than in higher
organisms such as the mouse. Further, the genetic tools available to
fly researchers are unparalleled in any organism short of the baker’s
yeast.
In this review, we discuss how conserved processes between
humans and Drosophila make the fly a powerful model to study
humanNDDs.We go on to describe genetic tools used to investigate
fly brain structure and function and give demonstrative examples
of discoveries in the fly that provide insight into the mechanisms
underlying human cognitive disorders. We seek to highlight the
power of the fly as a tool for understanding the etiology of NDDs,
however it is not within the scope of this manuscript to extensively
catalog discoveries made in the fly, nor is it to outline the more
technical details of experimental approaches used in Drosophila.
For a comprehensive review of fly tools used in the study of the
brain, see Venken et al. (2011) and for a more comprehensive
reviews of NDD-related genes studied in Drosophila, refer to
reviews by Restifo (2005), Bolduc and Tully (2009), Gatto and
Broadie (2011).2. Drosophila and mammals share the basic building blocks
necessary for brain function and behavior
Many principles of the nervous system seem to have remained
unchanged across evolutionary lineages. This has led to the
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a single ancestor that possessed a sophisticated and highly robust
nervous system, developmentally stable enough to withstand
evolutionary changes without altering basic structure and function
(Ghysen, 2003). The use of animal models, and D. melanogaster in
particular, to understand the genetic and molecular mechanisms of
NDDs hinges on this fact.
For example, flies and humans share, to a considerable extent,
the genetic inventory necessary for building a brain (Thor, 1995). In
the context of human disease and disorders, up to two thirds of
human disease genes reported in the Online Mendelian Inheritance
in Man (OMIM) database have a homolog in the fruit fly (Reiter
et al., 2001) and the conservation of ID genes is particularly high:
up to 87% haveD. melanogaster homologs (Inlow and Restifo, 2004).
In fact, several human ID genes have been named after their
Drosophila homologs since mutant phenotypes for these genes
were first identified in the fly prior their discovery as ID genes in
humans (Inlow and Restifo, 2004). The identification of MR genes
and their cataloging in OMIM is reviewed in depth by Inlow and
Restifo (2004), with a particular focus on Drosophila homologs. A
valuable online tool is Homophila, a cross-genomic database that
lists fruit fly homologs of all known human disease genes registered
in OMIM (Chien et al., 2002) (Table 1).Table 1
Major NDDs modeled in the fly.
Neurodevelopmental disorder Human gene
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mention the tractability of the fly as a model system. The genomes
of mammalian models are more complex than Drosophila in part
because they bear larger gene families. Members of a gene family
can be functionally redundant, or a common function can be par-
titioned among paralogs. As an evolutionary mechanism, this
buffers against genetic mutations and allows innovation of new
function from extant genes (Ohno, 1970), but in practice this makes
mammals more challenging models for understanding genome
function. For example, many genes linked to NDDs have several
paralogs in humans, while in the fly, are found as only a single
homolog. Specifically, fxr-1 and fxr-2 are two paralogs of the
Fragile-X mental retardation (fmr-1) gene in humans and mice,
whereas Drosophila has a single fmr-like gene (Wan et al., 2000).
Reducing genetic complexity introduced by post-transcriptional
processing further aids in studying the genetic basis of NDDs as it
may unmask mutations causing subtle phenotypes. For example
the mRNA MAPK-activated ribosomal S6 Kinase (rsk) e mutations
for which are associated with Coffin-Lowry syndrome e has four
isoforms in humans, while Drosophila has only one (Romeo et al.,
2012).
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(Bellen et al., 2010; Reichert, 2002; Reichert and Simeone, 1999;
Rubin et al., 2000). Strong demonstrations of this have come from
studies of genetic complementation, in which a gene from
Drosophila can functionally replace its mammalian homolog or
vice-versa (Bonini, 2000). For example, the mouse and human gene
math1, critical for normal neuronal development, has a counterpart,
atonal, first discovered in flies that can completely functionally
complement CNS and PNS defects in math1-deficient mice (Wang
et al., 2002). In turn, atonal mutant phenotypes can be reversed
with the expression ofmath1 in the fly (Wang et al., 2002). Another
example is the otx gene family, disruptions in which lead to brain
abnormalities including reduced brain size and neuronal defects
that ultimately cause epileptic seizures in mice (Acampora et al.,
1996; Sancini et al., 2001). Mouse otx1 ortholog can alleviate the
corollary phenotype in fliese loss of anterior head structurese and
likewise many of the mouse phenotypes are complemented by the
fly homolog otd (Nagaod et al., 1998; Acampora et al., 1998).
Along with a more complex genome, the interconnections
between neurons of the human brain are orders of magnitudemore
complex than that of the fly brain. Again, despite the vast organi-
zational differences in brain anatomy, the fly offers a powerful
simplification of human NDDs. This is because the cellular
components of mammalian and fly nervous systems are structur-
ally and developmentally comparable (Araujo and Tear, 2003;
Sanchez-Soriano et al., 2005; Hirth et al., 2003). For example, the fly
brain has a level of diversity and complexity of cell-types similar to
that of the human brain, however it is a more tractable system
because there are fewer total cells to work with. In fact, the fly’s
brain is small enough that one can microscopically peer at every
neuron at once in a single sample.
Furthermore, despite the more complex wiring patterns in
mammalian neurons, themechanisms cells use to connect with one
another are evolutionarily conserved. Like mammalian neurons, fly
neurons have axons and dendrites that follow evolutionarily
conserved molecular guidance cues e such as Netrins, Slits, Sem-
aphorins, and Ephrins e to extend to and connect with their
synaptic targets (Dickson, 2002). Once connected, fly and human
neurons use the same mechanisms for inter-cellular communica-
tion, such as action potentials and neurotransmitter signaling.
Evolutionarily conserved Naþ, Kþ, and Caþþ ion channels main-
tain cell voltage and regulate firing of action potentials (Littleton
and Ganetzky, 2000). Shared vesicular trafficking mechanisms
allow the release of universal neurotransmitters such as GABA,
glutamate and acetylcholine to mediate synaptic signaling
(Littleton, 2000; Nichols, 2006). Interestingly, the fly brain can
respond to human psychoactive drugs such as ethanol and cocaine,
further suggesting conservation of molecular pathways underlying
brain function at the network level (Heberlein, 2000; Heberlein
et al., 2009). In fact, the Drosophila model serves as a valuable
platform for neuropharmacological research and has been
successfully used to identify therapeutic approaches to several
brain disorders such as Huntington’s and Fragile X Syndrome
(Nichols, 2006; Steffan et al., 2001; McBride et al., 2005; Choi et al.,
2010;Manev et al., 2003). These findings have provided impetus for
similar studies in mouse models and clinical trials with Fragile X
patients.
NDDs are essentially characterized by defects in cognition and
behavior, and a functioning human brain presumably generates
more sophisticated cognitive output than that of a fly. These
sophisticated cognitive functions allow us to have emotions,
nurture our young and plan for the future. Nevertheless, the fly is
capable of its own suite of complicated behaviors (Greenspan and
van Swinderen, 2004), and the most basic behaviors of humans
and flies are again shared. The plasticity of their nervous systemsallows flies to habituate to sensory stimuli, and learn and form
memories of associations through various training modules
(Pitman et al., 2009). Flies have diurnally rhythmic activity patterns,
and require sleep for proper brain function (Hardin, 2005; Cirelli
and Bushey, 2008). They also have social behaviors that can be
systematically assayed, such as sophisticated courtship rituals and
aggressive interactions fueled by hunger or the desire to mate
(Dankert et al., 2009). These albeit simple examples are nonethe-
less the most conserved and critical functions required for survival,
and have been extensively studied in flies.
Perhaps more importantly, many genetic and molecular
underpinnings of behavior are shared between humans and flies
(Greenspan and Dierick, 2004). The genes driving human NDDs like
Fragile X Syndrome, Kleefstra Syndrome, Neurofibromatosis type 1,
Angelman Syndrome, MRT1 and Coffin-Lowry Syndrome have
homologs in the fly that lead to learning and memory defects akin
to those in humans (McBride et al., 2005; Kramer et al., ; Guo et al.,
2000; Wu et al., 2008; Didelot et al., 2006; Putz et al., 2004). This
makes the fly relevant to the study how functional disruptions in
these genes can lead to ID-like deficits. Furthermore, the fly can
serve as a platform for the de novo discovery of genes likely to
underpin human cognitive disorders (Inlow and Restifo, 2004;
Morley and Montgomery, 2001), and thereby contribute signifi-
cantly to our understanding of neurobiological processes relevant
in human behavioral disorders. Indeed, the study of behavioral
neurogenetics in flies e pioneered by Seymour Benzer in 1960s e
led to the isolation of many key genes that affect neuronal functions
involved in circadian rhythm, learning andmemory and has laid the
foundations for our understanding of many human neurological
processes (Bellen et al., 2010; Vosshall, 2007). For example, iden-
tified in the behavioral screens of Benzer, dunce (Dudai et al., 1976)
and rutabaga mutants led to the discovery of the role that cAMP
synthesis plays in learning and memory, a pathway implicated in
several NDDs in humans (Kelley et al., 2007; Al-Tawashi et al.;
Mironov et al.; Bourtchouladze et al., 2003).3. Experimental approaches in Drosophila
Nervous system development and function can be studied on
many different scales, starting from the biophysical and molecular
interactions in single cells to the behavior and social interactions of
the organism. Due to its exceptional experimental tractability, the
fruit fly provides one of the most powerful models to explore these
scales. A continuously expanding genetic toolbox, the use of well-
established anatomical probes, biochemical assays, live imaging
techniques, physiological recordings, and a battery of behavioral
tests allow the study of fly brain structure and function in its
entirety (Venken et al., 2011). In the following sections, we outline
the use of genetic experimental approaches.4. Identification and analysis of new genes
Flies are effective tools for the discovery of novel genes involved
in nervous system development and function. Their genetic back-
ground and environmental conditions can be tightly controlled,
and because they are highly fertile and have short generation times,
they can be analyzed in large enough numbers to detect rare
phenotypes. This is particularly important in the study of NDDs,
since these disorders are dramatically influenced by synergistic
genetic and environmental interactions, and thus typically occur
with variable penetrance and expressivity. Moreover, the largely
unbiased nature of genetic screens in Drosophila allows for insights
into mechanisms that may be relevant to disease pathology
without prior knowledge or potentially erroneous assumptions.
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In forward genetic screens, randomly mutagenized lines of flies are
screened for disruptions in a particular phenotype (such as defects
in learning and memory). In contrast, reverse genetic approaches
focus on identifying the phenotypic consequences of altering
specific genes.
For forward genetic screens, libraries of flies are first created
by random mutagenesis using chemicals, irradiation or
transposon-mediated genetic disruptions (St Johnston, 2002).
After generation of the library, it is the researchers’ task to screen
individual mutants for defects in a function of interest. Using this
approach, hundreds of genes involved with the development of
particular anatomical features or behavioral deficits have been
discovered. The challenge, however, lies in identifying the nature
and genomic position of the randomly disrupted gene. This is
particularly true for the standard chemical mutagen used in the
fly, called ethylmethane sulfonate (EMS). EMS treatment is easy to
administer and produces frequent point mutations at random
that can saturate the entire genome. Because point mutations can
lead to partial or complete loss of function, this approach can
unveil the role played by genes essential for the survival of the
organism. Furthermore, chemical mutagenesis can offer insight
into critical residues required for gene function. Unfortunately, it
has traditionally been difficult to map and unravel the specific
mutations underlying the identified phenotype. However, this
mutagen remains popular today due to the recent development
of approaches that exploit the power of whole-genome
sequencing.
An alternative way to screen for novel genes is via transposon-
mediated mutagenesis. To generate the mutant library, flies are
first induced to have genetically engineered transposable elements
insert throughout the genome, disrupting one or a few genes. Then
traditional screening approaches are used to identify affected
phenotypes. One advantage to this approach is that transposon
insertions typically result in partial loss of function, which allows
the study of genes that are required for survival. Moreover, trans-
poson mutagenesis is particularly effective in the search for new
genes because the genomic location of the insertions can be easily
recovered using standard laboratory techniques. There are already
extensive collections of transposon insertion lines available for
screening and functional analysis.
While forward screens are used in the discovery of novel genes
involved with a given phenotype, reverse genetic screens help to
explore the function of a particular gene, such as a homolog of
a known human disease gene (St Johnston, 2002). Using reverse
genetic strategies, a gene is targeted for disruption, and subse-
quently the researcher goes on to characterize the phenotypic
consequences. In the fly, genes can be disrupted by deletions, RNAi
or by site-specific knock-out and knock-ins. Transposon libraries
are also used in reverse genetic approaches: genomic lesions can be
generated either by inducing the imprecise excision of the trans-
poson or by the splicing of sequences flanked by two different
transposons. Currently, deletion collections generated by this
method span almost all of the genome are available to fly
researchers. Alternatively, RNA interference can be used to effec-
tively down-regulate fly genes in vivo using binary expression
systems (outlined in the next section). Interestingly, genome-wide
RNAi screens blur the distinction between forward and reverse
genetics.
Lastly, homologous recombination can be used to specifically
target genes to be knocked-out or replaced (“knocked-in”) with
other genes or alleles of interest (Rong et al., 2002). These genetic
modifications are initially time-consuming and laborious due to the
low efficiency of homologous recombination in flies. However, once
the gene of interest is replaced with a genetic construct that allowsfor cassette exchange, subsequent knock-in experiments are far
more efficient (Choi et al., 2009).
Finally, modifier screens combine forward and reverse genetics
to identify interactions between genes (St Johnston, 2002). In this
approach, a reverse-engineered mutant with a specific phenotype
serves as “sensitized background”, which is then crossed with
randomly mutagenized flies or RNAi lines to identify genes that
suppress or enhance the phenotype of interest. Because this type of
screen reveals epistatic interactions, it can identify genes that
normally would not show up in a traditional forward-genetics
screen. For example, this approach has been useful for the
discovery of several genetic modifiers for MeCP2 (Cukier et al.,
2008), the gene responsible for most cases of Rett’s Syndrome.
This study nicely illustrates a broadly used approach for identifying
pathways for human genes that do not have homologs in
Drosophila. The authors overexpressed MeCP2 in the fly eye, which
causes defects in eye development. They subsequently used
a candidate gene approach to search for genes whose dosage
reduction compensates for MeCP2 overexpression, identifying
several interactors in the process. Follow up studies with the
interacting gene osa suggest that MeCP2 gain of function affects
dendrite morphology in neurons (Vonhoff et al., 2012).
The screening approaches outlined above have led to the
isolation of many key genes involved in the biology of the nervous
system, such as neuronal specification, growth cone guidance,
synaptic transmission, circadian rhythmicity, learning and memory
(Dudai et al., 1976; Doe, 2008; Hartenstein et al., 2008; Vactor et al.,
1993; Seeger et al., 1993; Suzuki et al., 1971; Konopka and Benzer,
1971; Cirelli, 2003). Of particular relevance to NDD studies,
learning and memory mutants identified in the fly have been
proposed to reveal putative ID genes (Morley and Montgomery,
2001). In fact, several genes such as cheerio and rsk identified in
unbiased screens for learning and memory (Putz et al., 2004;
Dubnau et al., 2003) in flies have human homologs implicated in ID
disorders, clearly demonstrating the power of fly screening
approaches in the identification of putative NDD genes.
5. Targeted control of gene expression to unravel gene
function
As mentioned earlier, the nervous system has evolved to be as
robust as possible to environmental and genetic changes. This
means that the nervous system e and the organism as a whole e
works as hard as possible to adapt to the inevitable unpredictability
of its genome and the environment. However, from a technical
point of view, this robustness can mask phenotypes that reveal the
true role that a gene plays in development. Therefore, a large fly
genetic toolbox has been created for reverse genetic approaches to
allow cell-type and developmental-stage specific control of gene
expression (Venken et al., 2011). By downregulating or increasing
a specific gene’s expression in specific cell-types, we can study
phenotypes that the system’s inherent mechanisms of robustness
would otherwise obscure. Moreover, spatio-temporal genetic
control allows analysis of essential genes, which if mutated
throughout the entire organism would cause lethality. Below we
briefly outline some technical aspects of these tools.
Themost commonly used elements in the fly genetic toolbox are
microbially-derived binary expression systems. These expression
systems consist of two genetic elements: an exogenous transcrip-
tion factor and a synthetic promoter containing its binding
sequence. A specific endogenous fly gene promoter drives expres-
sion of the transcription factor. In turn, this transcription factor
specifically binds to a synthetic promoter to drive the expression of
the selected transgene. This can be simply a gene of interest,
a marker like a fluorescent protein, or an RNAi construct to target
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binary system used in the fly involves the yeast-derived tran-
scription factor Gal4, which binds to the Upstream Activator
Sequence (UAS) to drive transgene expression (Brand and
Perrimon, 1993). Other recently developed binary expression
systems such as the LexAop and QF:QUAS system can be used in
parallel with the Gal4eUAS system to achieve more complex
expression dynamics (Szuts and Bienz, 2000; Lai and Lee, 2006;
Potter et al., 2010). The advent of new binary expression systems
that do not cross-react means that different transgenes, such as
markers, RNAi constructs and overexpression constructs can be
expressed simultaneously in exclusive or overlapping patterns. This
opens the door to examining genetic interactions and cellular
interactions in parallel. The Q system is particularly promising
because, like the Gal4 system and its repressor Gal80, includes
a repressor protein, QS. Furthermore, it can be de-repressed using
a chemical, Quinic Acid (QA) which adds another layer of control.
Endogenous promoters differentially drive expression of genes
in specific cell types, during specific life stages. Binary expression
systems take advantage of this to provide spatio-temporal control
of the gene studied, which greatly expands the potential for anal-
ysis of gene function. The use of binary expression systems has been
critical in the study of NDD genes in Drosophila; for example, the
UASeGal4 system has been used extensively to characterize
neuronal morphology defects in the fmr mutant fly (Fig. 1).
By restricting the expression of a transgene only to cells of
interest, at a select developmental stage, one can also overcome
a number of technical obstacles, such as the ability to visualize and
modulate activity in distinct cellular populations. For instance, by
coupling the Gal4 transcription factor to a gene promoter specifi-
cally expressed in a neuronal or glial population, one can drive the
expression of a reporter gene such as GFP, to selectively visualize
these cells. Depending on the localization properties of the reporter
gene, the system can be used to mark specific sub-cellular struc-
tures. This is achieved by fusing the UAS-coupled fluorescent
reporter gene with a compartmental protein which localizes to the
cell membrane, cytoplasm, mitochondria, nucleus, nucleolus,
dendrites, synapse, ER or Golgi. Labeling groups of cells and specificFig 1. Using the UASeGal4 expression system to study neuronal architecture in fly FXS m
described by Wan et al. (2000). Subsequent studies established that the loss of fmr in the fl
neuronal populations such as the ‘pacemaker’ Lateral Ventral neurons (LNv) (Reeve et al.,
overexpression of fmr using the UASeGal4 system in these neurons decreases neuronal branc
et al., 2003). This is in line with the observation that fmr negatively regulates structural elabo
autonomous, since the overexpression of a dominant-negative allele of Drosophila fmr exclu
observed in the full mutant (Reeve et al., 2008).cellular structures provides the ability to assess loss of function
phenotypes within specific populations of neuronal cells. For
instance this approach is used in the fly model of Fragile X
syndrome to reveal excessive dendritic and axonal over-elaboration
in a number of neuronal populations (Fig. 1).
Numerous Gal4 lines with characterized expression patterns
have become available to fly researchers through commercial fly
stocks. In addition, research groups in Janelia Farm (HHMI Janelia
Farm, VA, US) have recently generated thousands of novel Gal4
lines, and are in the process of characterizing the spatio-temporal
pattern of expression associated with each stock (Pfeiffer et al.,
2008). These efforts are likely to produce enough lines with
distinct expression patterns to allow analysis of the majority of
neuronal and glial populations in the brain.
Using Gal4 elements to drive expression of reporters is also
useful for discovering populations of cells inwhich a certain gene is
expressed and establishing their function in driving behavior. To
identify which cells express a gene of interest, a Gal4 line with the
promoter of a gene with known function can simply drive
expression of a GFP reporter, illuminating all cells which express
that gene. This approach has been used to characterize and group
classes of pacemaker neurons involved in circadian rhythm of flies
(Shafer et al., 2008).
Using similar approaches, binary expression systems can be
used to alter cell physiology within specific neuronal populations
(Venken et al., 2011; Keene and Waddell, 2007). For instance, Gal4
lines can be used to drive the expression of exogenous toxins or
proapaptotic genes to eliminate a select set of neurons, and
thereafter observe the functional and behavioral consequences.
Alternatively, altering the expression of specific ion channels in
a neuronal population can enhance or hamper electrophysical
activity in these cells. These powerful techniques that modulate the
activity of certain population of cells helps understand their niche
within the nervous system, how they participate in development
and how they affect behavior.
Binary expression systems in the fly can be further regulated by
extrinsic factors acting on the system, such as temperature, thereby
providing a temporal control of transgene expression. For example,odel. The Drosophila homolog of Fragile X mental retardation gene (fmr-1) was first
y nervous system results in excessive elaboration and overgrowth of axons in various
2005; Reeve et al., 2008; Michel et al., 2004; Lee et al., 2003). On the other hand, the
hing and restricts growth (Reeve et al., 2005; Reeve et al., 2008; Michel et al., 2004; Lee
ration in fly neurons. Moreover, the requirement for fmr in the LNvs appears to be cell-
sively in the LNvs of a wild-type animal results in the same loss of function phenotype
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Gal4 transcriptional activator e and so can be used to inhibit Gal4
expression only at permissive temperatures (McGuire et al., 2003).
Another way to interfere with driver expression is to use drug-
inducible Gal4 systems (Stebbins et al., 2001; Roman et al., 2001).
Having temporal control over gene expression helps uncouple
developmental defects from adult-specific defects in a mutant,
which is a crucial step in understanding NDD etiology and devising
potential therapeutics. For instance, the drug inducible Gene-
Switch system has revealed that fly memory defects observed in
the absence of the fly homolog of Neurofibramatosis type 1 (dNF1)
is mostly an adult stage defect, and can be rescued with the
expression of dNF1 specifically in the adult stage (Buchanan and
Davis, 2010).
Finally, binary expression systems can be used to induce
genome-level disruptions in single cells within the brain (Venken
et al., 2011). In particular, controlled expression of the yeast FLP
recombinase can cause precise mitotic recombination between
sister chromatids at specifically engineered FRT sites. If done in
a background that is heterozygous for the recombined gene region,
one of the resulting daughter cells e that is now homozygous for
the mutation e can be directly examined within its organic or
developmental setting (Lee and Luo, 2001). This method is partic-
ularly useful for studying the stage-specific, cell-autonomous
requirement of a gene with diverse functions in different tissues
and at different developmental stages. For instance, clonal analyses
using this system have revealed the role of Drosophila fmr in the
proliferation capacity of neural stem cells in the brain: fmr null
neuroblasts give rise to more neurons compared to the control
neuroblasts in the same organism (Callan et al., 2010).
The FRTeFLP system is also useful for the stochastic labeling of
cells. As mentioned above, a Gal4 element can be used to drive the
expression of a reporter gene in a specific population of neurons.
Introducing FLPeFRT into this system can help restrict the
expression of the reporter gene to only a single or few cells. For
instance, engineering a stop cassette e flanked by FRT sites e
between the UAS element and the reporter gene can block the
expression of the reporter in all Gal4 expressing cells, except in
those with induced FLP gene expression. The stochastic labeling of
a few cells helps visualize neuronal architecture with single-cell
resolution as well as allowing for lineage tracing of cells
(Hadjieconomou et al., 2011; Lee, 2009).
6. Conclusion
D. melanogaster is established as a valuable research organism
for the study of many human diseases including neuro-
developmental disorders (Bellen et al., 2010; Bier, 2005; Leyssen
and Hassan, 2007). The power of the fly model in investigating
NDD etiology stems from the fact that the genetic and molecular
logic, and basic architecture of its nervous system is, to a very large
extent, shared by mammals. In addition, the experimental tracta-
bility of the fly surpasses that of all higher eukaryote models; an
extensive collection of genetic tools and experimental techniques
allows us to thoroughly investigate gene function at the cellular and
behavioral level. Flies are easy to rear in large numbers, which gives
the possibility to do large-scale experiments and use screening
approaches. Genetic screens are extremely effective in identifying
novel genes, their function in the nervous system and their
particular context within a molecular pathway. Thus, the fruit fly
model is optimal for initial discovery and characterization of NDD
genes and molecular pathways that can then be further investi-
gated in the mammalian context. Finally, an emerging trend in fly
research is to investigate geneeenvironment interactions and its
influence on the phenotypic outcome. This is likely to turn out to bean important aspect of studying NDDs, due to its implications
regarding pre-natal care and educational opportunities for indi-
viduals suffering from these disorders.
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